REFERENCES
[1] Ferlay J, Shin HR, Bray F, et al. Lyon, France: International Agency for Research on Cancer; 2010. GLOBOCAN 2008 v 1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 10
[2]  Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Diabetes mellitus and risk of prostate cancer (United States) Cancer Causes Control.  1998;9:3–9.
[3]. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev.  1997;6:557–63.
[4]. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, et al. Association of smoking, body mass and physical activity with risk of prostate cancer in the lowa 65+ Rural Health Study (United States) Cancer Causes Control.  1997;8:229–38.
[5]. Alyson LJ, White E, Kristal AR. Anthropometrics and prostate cancer risk. Am J Epidemiol.  2007;165:1271–9
[6]. Platz EA, Yeole BB, Cho E, Jussawalla DJ, Giovannucci E, Ascherio A. Vasectomy and Prostate Cancer: A case - control study in India. Int J Epidemiol.  1997;26:933–8.
[7]. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol . 2011;59(1):61-71. doi:10.1016/j.eururo.2010.10.039
[8]. Evans AJ. Treatment effects in prostate cancer. Mod Pathol . 2018;31(S1):S110-S121. doi:10.1038/modpathol.2017.158
[9] Matsushita M, Fujita K, Nonomura N. Influence of Diet and Nutrition on Prostate Cancer. Int J Mol Sci . 2020;21(4):1447. Published 2020 Feb 20. doi:10.3390/ijms21041447 [10] Graff RE, Pettersson A, Lis RT, et al. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J ClinNutr . 2016;103(3):851-860. doi:10.3945/ajcn.115.118703
[11] A. Kawashima, T. Madarame, H. Koike, Y. Komatsu, J.A. Wise, Four week supple-mentation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects, Asia Pac. J. Clin. Nutr. 16 (2007) 411–421
[12]M. Ono, M. Takeshima, S. Nakano, Mechanism of the Anticancer Effect of Lycopene(tetraterpenoids), the Enzymes, Elsevier, 2015, pp. 139–166.
[13]V. Bhuvaneswari, S. Nagini, Lycopene: a review of its potential as an anticanceragent, Curr. Med. Chem. Anticancer Agents 5 (2005) 627–635.
[14]N.F. Gloria, N. Soares, C. Brand, F.L. Oliveira, R. Borojevic, A.J. Teodoro, Lycopeneand beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer celllines, Anticancer Res. 34 (2014) 1377–1386.
[15]U.C. Obermüller-Jevic, E. Olano-Martin, A.M. Corbacho, J.P. Eiserich, A. Van derVliet, G. Valacchi, C.E. Cross, L. Packer, Lycopene inhibits the growth of normalhuman prostate epithelial cells in vitro, Nutr. J. 133 (2003) 3356–3360.
[16]Y. Sharoni, M. Danilenko, J. Levy, Molecular mechanisms for the anticancer activityof the carotenoid lycopene, Drug Dev. Res. 50 (2000) 448–456.
[17]J. Levy, E. Bosin, B. Feldman, Y. Giat, A. Miinster, M. Danilenko, Y. Sharoni,Lycopene Is a More Potent Inhibitor of Human Cancer Cell Proliferation Than Eitherα‐carotene orβ‐carotene,(1995).
[18]H. Nagasawa, T. Mitamura, S. Sakamoto, K. Yamamoto, Effects of lycopene onspontaneous mammary tumour development in SHN virgin mice, Anticancer Res.15 (1995) 1173–1178.
[19]M.-C. Lin, F.-Y. Wang, Y.-H. Kuo, F.-Y. Tang, Cancer chemopreventive effects oflycopene: suppression of MMP-7 expression and cell invasion in human coloncancer cells, J. Agric. Food Chem. 59 (2011) 11304–11318.
[20]D. Li, L. Chen, W. Zhao, J. Hao, R. An, MicroRNA-let-7f-1 is induced by lycopeneand inhibits cell proliferation and triggers apoptosis in prostate cancer, Mol. Med.Rep. 13 (2016) 2708–2714.
[21]N.F. Haddad, A.J. Teodoro, F.L. de Oliveira, N. Soares, R.M. de Mattos, F. Hecht,R.S. Dezonne, L. Vairo, R.C. Dos Santos Goldenberg, F.C.A. Gomes, Correction: ly-copene and beta-carotene induce growth inhibition and proapoptotic effects onACTH-Secreting pituitary adenoma cells, PLoS One 11 (2016) e0149157.
[22]S.-A. Esmaeili, F. Nejatollahi, A. Sahebkar, Inhibition of intercellular communica-tion between prostate cancer cells by a specific anti-STEAP-1 single chain antibody,Anticancer Agents Med. Chem. 18 (2018) 1674–1679
[23] Chen P, Zhang W, Wang X, et al. Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) . 2015;94(33):e1260. doi:10.1097/MD.0000000000001260
[24] Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst . 2002;94(5):391-398. doi:10.1093/jnci/94.5.391
[25] Chen J, Song Y, Zhang L. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. J NutrSciVitaminol (Tokyo) . 2013;59(3):213-223. doi:10.3177/jnsv.59.213
[26] Chen P, Zhang W, Wang X, et al. Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) . 2015;94(33):e1260. doi:10.1097/MD.0000000000001260